Russell Steven Jon 4
4 · Beta Bionics, Inc. · Filed Sep 4, 2025
Insider Transaction Report
Form 4
Russell Steven Jon
Chief Medical Officer
Transactions
- Sale
Common Stock
2025-09-02$18.86/sh−1,015$19,146→ 71,017 total
Footnotes (2)
- [F1]The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.
- [F2]The weighted average sale price for the transaction reported was $18.8632 and the range of prices were between $18.58 and $19.09. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.